Transforming growth factor-β1 (TGF-β1) induces mouse precartilaginous stem cell differentiation through TGFRII-CK1ε-β-catenin signalling

Int J Exp Pathol. 2018 Jun;99(3):113-120. doi: 10.1111/iep.12275. Epub 2018 Aug 2.

Abstract

Precartilaginous stem cells (PSCs) are adult stem cells which could self-renew or differentiate into chondrocytes to promote bone growth. In this study, we aimed to understand the role of transforming growth factor-β1 (TGF-β1) in precartilaginous stem cell (PSC) differentiation and to study the mechanisms that underlie this role. We purified PSCs from the neonatal murine perichondrial mesenchyme using immunomagnetic beads, and primary cultured them. Their phenotype was confirmed by the PSC marker fibroblast growth factor receptor-3 (FGFR-3) overexpression. TGF-β1 was added to induce PSCs differentiation. TGF-β1 increased mRNA expression of chondrogenesis-related genes (collagen type II, Sox 9 and aggrecan) in the cultured PSCs. This was abolished by TGF-β receptor II (TGFRII) and Casein kinase 1 epsilon (CK1ε) lentiviral shRNA depletion. Meanwhile, we found that TGF-β1 induced CK1ε activation, glycogen synthase kinase-3β (GSK3β) phosphorylation and β-catenin nuclear translocation in the mouse PSCs, which was almost completely blocked by TGFRII and CK1ε shRNA knockdown. Based on these results, we suggest that TGF-β1 induces CK1ε activation to promote β-catenin nuclear accumulation, which then regulates chondrogenesis-related gene transcription to eventually promote mouse PSC differentiation.

Keywords: CK1ε; TGF-β1; chondrogenesis; differentiation; precartilaginous stem cells; signalling; β-catenin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult Stem Cells / drug effects*
  • Adult Stem Cells / enzymology
  • Aggrecans / genetics
  • Aggrecans / metabolism
  • Animals
  • Animals, Newborn
  • Casein Kinase 1 epsilon / genetics
  • Casein Kinase 1 epsilon / metabolism*
  • Cell Differentiation / drug effects*
  • Cell Differentiation / genetics
  • Cells, Cultured
  • Chondrocytes / drug effects*
  • Chondrocytes / enzymology
  • Chondrogenesis / drug effects*
  • Chondrogenesis / genetics
  • Collagen Type II / genetics
  • Collagen Type II / metabolism
  • Gene Expression Regulation, Developmental
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Mice, Inbred C57BL
  • Nuclear Transfer Techniques
  • Phenotype
  • Phosphorylation
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics
  • Receptor, Fibroblast Growth Factor, Type 3 / metabolism
  • Receptor, Transforming Growth Factor-beta Type II / agonists*
  • Receptor, Transforming Growth Factor-beta Type II / genetics
  • Receptor, Transforming Growth Factor-beta Type II / metabolism
  • SOX9 Transcription Factor / genetics
  • SOX9 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • Transforming Growth Factor beta1 / pharmacology*
  • beta Catenin / metabolism*

Substances

  • Aggrecans
  • CTNNB1 protein, mouse
  • Collagen Type II
  • SOX9 Transcription Factor
  • Sox9 protein, mouse
  • Transforming Growth Factor beta1
  • beta Catenin
  • Fgfr3 protein, mouse
  • Receptor, Fibroblast Growth Factor, Type 3
  • Casein Kinase 1 epsilon
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, mouse
  • Receptor, Transforming Growth Factor-beta Type II
  • Tgfbr2 protein, mouse